About a quarter of the weight people lose on incretin therapy is lean tissue rather than fat.1

Nearly two thirds of US adults who start a GLP-1 for obesity have stopped taking it within a year.2

Weight loss should cost people fat, and nothing else.

Please note: Halovance Bio operates in a stealth capacity.

This reaches us directly. We use what you send only to respond. Privacy notice.